Bengaluru, India—Sami-Sabinsa Group hosted a ground-breaking ceremony on January 20, 2020, for a new Active Pharmaceutical Ingredients (API) manufacturing unit at Pharma SEZ Industrial Area, Hassan, Karnataka, according to a press release. It is part of the group’s strategy to expand existing ingredient growth and focus on innovative new products. It will be the company’s eighth manufacturing facility. It is scheduled for commissioning by 2021 and is expected to generate employment for approximately 400 people in the area.

The first phase, covering 430,556 square feet of the unit, will have a production capacity of more than 300 tons per annum. The Zero Liquid Discharge facility will be environmentally conscious, combining responsible water management, biodiversity development, and energy efficiency.
Related: Sabinsa Recognized by NJBIZ Sustainable Business: Serving a Worthy Purpose Sami-Sabinsa Group Honored with Multiple Awards
The ceremony was attended by Member of Parliament Shri. Prajwal Gowda and Member of the Legislative Assembly Shri. Preetham J. Gowda, along with the senior management team of Sami-Sabinsa Group and employees of Sami Labs.

Dr. Muhammed Majeed, Founder and Chairman of the Sami-Sabinsa Group, said in the release: “We have been doing business in India for nearly three decades now, and our business has grown rapidly over the years. The upcoming production facility at Hassan will not only empower us to cater to the entire global market with patented and off-patent API products, but will also play a vital role in boosting the export sales of the Sami-Sabinsa Group and help in doubling the company revenue.”